Tag: gastroparesis market growth

Uncover key drivers, emerging technologies, and competitive movements shaping the gastroparesis market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Gastroparesis Market between 2026 and 2030?

The gastroparesis market has experienced robust expansion in recent years. Projections indicate it will increase from $7.15 billion in 2025 to $7.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. Historically, this market’s expansion can be linked to factors like diabetes-related gastric disorders, the application of antiemetic medications, specialized hospital-based GI care, various dietary management strategies, and the prevalence of diagnostic imaging.

The gastroparesis market is set to experience substantial growth in the coming years. It is forecast to reach $9.29 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.5%. This expansion during the forecast period can be attributed to innovations in implantable stimulation devices, the rise of outpatient treatment models, an increasing diabetic population, the demand for symptom-focused therapies, and improved clinical awareness. Key trends anticipated during this period include a heightened use of prokinetic medications, the growing adoption of gastric electrical stimulation devices, an increased focus on dietary and lifestyle management, the availability of more minimally invasive surgical options, and enhanced diagnosis of diabetic gastroparesis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Drivers Are Expected To Impact The Gastroparesis Market During The Forecast Period?

The gastroparesis market is expected to expand moving forward due to the escalating prevalence of diabetes. Diabetes is a chronic medical condition defined by elevated blood glucose levels, resulting from the body’s insufficient insulin production or its inability to use insulin effectively. The widespread occurrence of diabetes substantially raises the probability of developing gastroparesis, as diabetes plays a crucial role in enlarging the population susceptible to this ailment. For example, in April 2025, the International Diabetes Federation, a Belgium-based advocacy organization, reported that globally, nearly one in nine adults (589 million) are currently living with diabetes. Of these, an estimated 252 million are unaware they have the condition, which puts them at higher risk of serious complications and early death. Consequently, the rapid surge in the prevalence of diabetes is driving the gastroparesis market.

How Is The Gastroparesis Market Divided Into Segments?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

How Are New Market Trends Shaping The Landscape Of The Gastroparesis Market?

Leading companies in the gastroparesis market are actively developing pharmaceuticals to boost their profitability. Drugs utilized for treating gastroparesis serve diverse functions to manage symptoms associated with delayed stomach emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company, announced that the U.S. FDA had accepted the New Drug Application for Tradipitant, indicating a promising step towards its potential approval for gastroparesis treatment. The FDA has established September 18, 2024, as the decision date for Tradipitant under the Prescription Drug User Fee Act (PDUFA). If successful, Tradipitant would be the first FDA-approved novel drug for gastroparesis in over 40 years, representing a significant milestone as it would be the first drug to undergo specific FDA review for gastroparesis in more than three decades.

Which Leading Companies Dominate The Gastroparesis Market Share?

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastroparesis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2026, By The Business Research Company

Gastric Volvulus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Gastroparesis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Diabetic Gastroparesis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Gastroparesis Market?

The market size of gastroparesis has seen considerable growth in the last few years. The market is projected to expand from $6.84 billion in 2024 to $7.15 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. Factors such as an aging population, a rise in diabetes cases, enhanced knowledge of gastrointestinal disorders, changes in treatment tactics, and increased gastroparesis awareness are believed to be driving the growth seen in the past years.

The market for gastroparesis is projected to undergo substantial expansion in the coming years, with expectations to reach up to $8.78 billion by 2029, bolstered by a compound annual growth rate (CAGR) of 5.3%. The upcoming period’s growth is primarily driven by factors like the emergence of new therapeutic alternatives, growth of individualized medicine strategies, incorporation of digital health solutions, improvement in healthcare facilities, and emphasis on early detection. The forecast period will likely witness trends such as developments in gastric electrical stimulation treatments, an increase in stem cell therapy research, a tendency towards less invasive surgical procedures, an upsurge in the utilization of health-monitoring wearable devices, and a focus on care models centered on patients’ needs.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

What Drivers Are Accelerating Expansion Of The Gastroparesis Market?

The surge in expenses for health services is anticipated to drive the development of the gastroparesis market in the future. Healthcare expenses cover the total resources channeled into health services, including costs for hospitals, healthcare experts, nursing services, dental attention, medications, and public health endeavors. The spike in healthcare spending can be attributed to a variety of factors, such as a growing elderly populace, advancements in medical technologies, an increased prevalence of chronic diseases, and higher demands for superior healthcare services. The gastroparesis market is benefiting from the increased spending in healthcare, which affords more financial aid for research and development, broadens the range of treatment options, and allows more access for patients to special healthcare provisions. For instance, a study by the UK’s Office for National Statistics in May 2023, reported that the UK’s healthcare budget between 2022 and 2023, saw a growth of 5.6%, in contrast to a 0.9% increase in 2022. The UK spent roughly $317.63 billion (£292 billion) on healthcare in 2023. Consequently, the increase in healthcare expenditure is propelling the gastroparesis market forward.

What Are The Key Segment Trends Observed In The Gastroparesis Market?

The gastroparesismarket covered in this report is segmented –

1) By Treatment Modality: Medications; Dietary Modifications; Medical Devices; Other Therapies

2) By Gastroparesis Type: Idiopathic; Diabetic; Post- Surgical; Other Types

3) By Patient Demographics: Pediatric Gastroparesis; Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels

5) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents; Antiemetic Medications; Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets; Small, Frequent Meals; Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices; Enteral Feeding Tubes

4) By Other Therapies: Acupuncture; Behavioral Therapies; Nutritional Supplements

What Strategic Shifts And Innovations Are Influencing The Gastroparesis Market?

Leading firms in the gastroparesis market are focusing on creating cutting-edge devices to improve their market profitability. These devices are specifically designed medical equipment intended to manage or reduce the symptoms of gastroparesis, a condition which causes a delay in stomach emptying. For example, in 2022, the US-based medical device firm Enterra Medical Inc., unveiled its enterra therapy for gastroparesis treatment. The therapy system is based on an implanted neurostimulator which generates mild electrical pulses, that in turn can provide potential relief from chronic nausea and vomiting related to gastroparesis. This treatment method is aimed at individuals between 18 to 70 years old who suffer from chronic, persistent nausea and vomiting associated with gastroparesis of either diabetic or idiopathic origin.

Who Are The Major Stakeholders Operating In The Gastroparesis Market?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

What Regional Factors Are Accelerating Growth In The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2025, By The Business Research Company

Foundation Structure And Building Exterior Contractors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/foundation-structure-and-building-exterior-contractors-global-market-report

Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Serviced Office Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/serviced-office-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Gastroparesis Industry Compare Between 2025 And 2029?

The gastroparesis market size has shown consistent expansion in recent years. It is projected to increase from $6.84 billion in 2024 to $7.15 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. This historical growth can be linked to an aging population, the rising prevalence of diabetes, a better understanding of gastrointestinal disorders, developing treatment protocols, and increasing awareness about gastroparesis.

The gastroparesis market size is anticipated to undergo significant expansion over the next few years. It is forecast to reach $8.78 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.3%. The market’s growth during this period can be attributed to the creation of innovative therapeutic alternatives, the broader application of personalized medicine approaches, the integration of digital health solutions, enhancements in healthcare infrastructure, and an increased emphasis on prompt diagnosis. Prominent trends for the forecast period include progress in gastric electrical stimulation therapy, expanding research in stem cell therapy, the adoption of minimally invasive surgical procedures, wider usage of wearable health monitoring devices, and a focus on care models centered around patients.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Major Market Drivers Are Shaping The Future Of The Gastroparesis Market?

Increased spending on healthcare is anticipated to drive the expansion of the gastroparesis market in the future. Healthcare spending denotes the overall funds dedicated to health services, encompassing costs for hospitals, medical practitioners, nursing, dental services, pharmaceuticals, and public health programs. This rise in healthcare spending stems from several elements, including an aging demographic, advancements in medical technology, a greater occurrence of chronic conditions, and increased patient demands for enhanced healthcare provisions. The augmented healthcare expenditure positively impacts the gastroparesis market by offering increased financial backing for research and development, broadening available treatment options, and improving patient access to specialized medical care. As an illustration, a report from the UK government department, the Office for National Statistics, indicated that in May 2023, UK healthcare spending grew by 5.6% between 2022 and 2023, contrasting with a 0.9% increase in 2022. In 2023, the total healthcare expenditure in the UK reached approximately $317.63 billion (£292 billion). Consequently, the expanding healthcare expenditure is a key driver for the gastroparesis market.

What Are The Major Segment Types Covered In The Gastroparesis Market?

The gastroparesismarket covered in this report is segmented –

1) By Treatment Modality: Medications; Dietary Modifications; Medical Devices; Other Therapies

2) By Gastroparesis Type: Idiopathic; Diabetic; Post- Surgical; Other Types

3) By Patient Demographics: Pediatric Gastroparesis; Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels

5) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents; Antiemetic Medications; Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets; Small, Frequent Meals; Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices; Enteral Feeding Tubes

4) By Other Therapies: Acupuncture; Behavioral Therapies; Nutritional Supplements

What Key Innovation Trends Are Fueling Advancements In The Gastroparesis Market?

Leading companies in the gastroparesis market are developing innovative devices to boost their profitability. Devices for treating gastroparesis are medical tools or equipment designed to help manage or alleviate the symptoms associated with gastroparesis, a condition characterized by delayed emptying of the stomach. For instance, in 2022, Enterra Medical Inc., a US-based medical device company, introduced enterra therapy for the treatment of gastroparesis. The Enterra Therapy system uses an implanted neurostimulator to generate gentle electrical pulses, providing potential relief for chronic nausea and vomiting symptoms linked to gastroparesis. This therapy is specifically for individuals aged 18 to 70 years who experience chronic, intractable (drug-refractory) nausea and vomiting related to gastroparesis of either diabetic or idiopathic origin.

Which Leading Companies Dominate The Gastroparesis Market Share?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Is Projected To Lead The Gastroparesis Market During The Forecast Period?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastroparesis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2025, By The Business Research Company

Foundation Structure And Building Exterior Contractors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/foundation-structure-and-building-exterior-contractors-global-market-report

Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Serviced Office Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/serviced-office-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gastroparesis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Projections for the CAGR of the Gastroparesis Market Size From 2025 to 2034?#_x000D_

The size of the gastroparesis market has seen a consistent expansion over the recent years. It is projected to increase from $6.84 billion in 2024 to $7.17 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The market’s growth during the historical period is attributable to factors such as an aging population, a rise in the instances of diabetes, an enhanced comprehension of gastrointestinal disorders, advanced treatment methodologies, and an escalating consciousness about gastroparesis._x000D_

_x000D_

The market size for gastroparesis is predicted to experience substantial growth in the coming years, surging to $8.82 billion by 2029, with a compounded annual growth rate (CAGR) of 5.3%. This forecasted growth can be credited to factors such as the introduction of innovative therapeutic options, the growth in personalized medicine strategies, assimilation of digital health solutions, enhancement in healthcare infrastructure, and a heightened emphasis on early detection. The future trends include advances in gastric electric stimulation therapy, an upswing in stem cell treatment research, the acceptance of minimally invasive surgical procedures, a rise in the employment of wearable health monitoring equipment, and increased focus on patient-focused care models._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Gastroparesis Market?#_x000D_

The expansion of the gastroparesis market is expected to be influenced by the escalation in healthcare expenditure. This refers to the total funds channeled towards health-related services, including aspects like hospitals, doctors, nursing staff, dental treatments, medications, and public health initiatives. The surge in healthcare spending is a result of various factors such as a growing elderly population, advancement in medical technology, an increasing prevalence of chronic diseases, and elevated demand for superior healthcare facilities. The gastroparesis market is benefitting from the growth in healthcare expenditure as it avails more money for research, broadens treatment options, and assures easier patient access to specialized healthcare services. A report released by the Office for National Statistics, a government department based in the UK, stated that healthcare spending in the UK rose by 5.6% from 2022 to 2023. This was a significant growth compared to the 0.9% increase in 2022. Healthcare spending in the UK in 2023 was estimated at approximately $317.63 billion (£292 billion). Consequently, the rising health expenditure contributes to the growth of the gastroparesis market._x000D_

_x000D_

#How Is the Gastroparesis Market Segmented?#_x000D_

The gastroparesis market covered in this report is segmented –_x000D_

_x000D_

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies_x000D_

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types_x000D_

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis_x000D_

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels_x000D_

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings_x000D_

_x000D_

Subsegments:_x000D_

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications_x000D_

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets_x000D_

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes_x000D_

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Gastroparesis Market Growth?#_x000D_

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Gastroparesis Market?#_x000D_

Leading businesses in the gastroparesis market are inventing novel devices to enhance their market share earnings. Medical equipment for treating gastroparesis is designed to relieve or control the symptoms of gastroparesis, a disorder resulting in slow stomach emptying. For example, in 2022, US-based medical device firm, Enterra Medical Inc., launched Enterra therapy to treat gastroparesis. This therapy system drops in an implanted neurostimulator to deliver slight electrical impulses, potentially mitigating chronic nausea and vomiting symptoms related to gastroparesis. The treatment is targeted toward those aged 18 to 70 years who are suffering from chronic, drug-resistant nausea and vomiting caused by diabetic or idiopathic gastroparesis._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report_x000D_

_x000D_

#How Is the Gastroparesis Market Defined and What Are Its Core Parameters?#_x000D_

Gastroparesis is a medical condition characterized by the impairment or weakening of the stomach muscles, resulting in delayed emptying of stomach contents into the small intestine. Gastroparesis is treated by medications to stimulate stomach emptying and manage underlying conditions, and surgical interventions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Gastroparesis Market?

The escalation in spending on healthcare is anticipated to boost the future expansion of the gastroparesis market. The term healthcare expenditure denotes the collective funds devoted to health services, encompassing hospital-related costs, fees for medical professionals, nursing care, dental services, medicines, and public health programs. The surge in healthcare spending can be credited to various elements, such as a rising elderly demographic, advancements in medical technology, an increased prevalence of chronic diseases, and heightened consumer demands for superior healthcare services. The increase in healthcare expenditure is having a positive impact on the gastroparesis market by facilitating more monetary aid for research and development, broadening the range of treatment options, and enabling patients to have better access to specialized medical services. For example, in May 2023, a report from the Office for National Statistics, a government department based in the UK, showed that between 2022 and 2023, the total spending on healthcare in the UK surged by 5.6%, in comparison to a growth rate of 0.9% in 2022. The total healthcare spending in the UK was approximately $317.63 billion (£292 billion) in 2023. Hence, the escalation in healthcare expenditure is stimulating the gastroparesis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

#What Are the Key Projections for the CAGR of the Gastroparesis Market From 2025 to 2034?

In the past few years, the market size for gastroparesis has seen consistent growth. It is expected to expand from a worth of $6.84 billion in 2024, reaching $7.17 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the growth during the historic period include an aging population, rising incidence of diabetes, enhanced knowledge of gastrointestinal disorders, changes in treatment guidelines, and increased awareness about gastroparesis.

In the following years, the gastroparesis market size is slated to experience robust growth, reaching $8.82 billion by 2029 with a compound annual growth rate (CAGR) of 5.3%. The anticipated growth within the forecasted period is thanks to the emergence of innovative therapeutic options, the increasing trend towards personalized medicine, the integration of digital health solutions, enhancements in healthcare infrastructure, and a growing emphasis on early diagnosis. Key trends within this period encompass progress in gastric electrical stimulation therapy, expanding research in stem cell therapy, the preference for minimally invasive surgical procedures, the growing usage of wearable health monitoring devices, and an emphasis on patient-centric care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

What New Market Trends Are Reshaping theGastroparesis Market and Its Opportunities?

Leading corporations in the gastroparesis marketplace are creating cutting-edge devices to boost their market profitability. These treatment appliances for gastroparesis are specialized medical devices designed to administer or lessen the symptoms related to gastroparesis, a medical condition marked by the stomach’s delayed emptying process. For example, Enterra Medical Inc., an American medical device firm, launched the Enterra Therapy for gastroparesis treatment in 2022. The Enterra Therapy system uses an implanted neurostimulator that generates gentle electric pulses, offering potential reprieve from chronic nausea and vomiting symptoms related to gastroparesis. This therapy is specifically meant for individuals aged 18 to 70 years who are experiencing chronic, unmanageable (drug-refractory) nausea and vomiting associated with gastroparesis of diabetic or idiopathic origin.

Who Are the Leading Market Players Fueling Growth in the Gastroparesis Market Trend?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

How is the Global Gastroparesis Market Segemented?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Which Geographics are Influencing the Growth of the Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Gastroparesis Maret 2025, By The Business Research Company:

Specialty Trade Contractors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/specialty-trade-contractors-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Gastroparesis Market?

The escalation in spending on healthcare is anticipated to boost the future expansion of the gastroparesis market. The term healthcare expenditure denotes the collective funds devoted to health services, encompassing hospital-related costs, fees for medical professionals, nursing care, dental services, medicines, and public health programs. The surge in healthcare spending can be credited to various elements, such as a rising elderly demographic, advancements in medical technology, an increased prevalence of chronic diseases, and heightened consumer demands for superior healthcare services. The increase in healthcare expenditure is having a positive impact on the gastroparesis market by facilitating more monetary aid for research and development, broadening the range of treatment options, and enabling patients to have better access to specialized medical services. For example, in May 2023, a report from the Office for National Statistics, a government department based in the UK, showed that between 2022 and 2023, the total spending on healthcare in the UK surged by 5.6%, in comparison to a growth rate of 0.9% in 2022. The total healthcare spending in the UK was approximately $317.63 billion (£292 billion) in 2023. Hence, the escalation in healthcare expenditure is stimulating the gastroparesis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

#What Are the Key Projections for the CAGR of the Gastroparesis Market From 2025 to 2034?

In the past few years, the market size for gastroparesis has seen consistent growth. It is expected to expand from a worth of $6.84 billion in 2024, reaching $7.17 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the growth during the historic period include an aging population, rising incidence of diabetes, enhanced knowledge of gastrointestinal disorders, changes in treatment guidelines, and increased awareness about gastroparesis.

In the following years, the gastroparesis market size is slated to experience robust growth, reaching $8.82 billion by 2029 with a compound annual growth rate (CAGR) of 5.3%. The anticipated growth within the forecasted period is thanks to the emergence of innovative therapeutic options, the increasing trend towards personalized medicine, the integration of digital health solutions, enhancements in healthcare infrastructure, and a growing emphasis on early diagnosis. Key trends within this period encompass progress in gastric electrical stimulation therapy, expanding research in stem cell therapy, the preference for minimally invasive surgical procedures, the growing usage of wearable health monitoring devices, and an emphasis on patient-centric care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

What New Market Trends Are Reshaping theGastroparesis Market and Its Opportunities?

Leading corporations in the gastroparesis marketplace are creating cutting-edge devices to boost their market profitability. These treatment appliances for gastroparesis are specialized medical devices designed to administer or lessen the symptoms related to gastroparesis, a medical condition marked by the stomach’s delayed emptying process. For example, Enterra Medical Inc., an American medical device firm, launched the Enterra Therapy for gastroparesis treatment in 2022. The Enterra Therapy system uses an implanted neurostimulator that generates gentle electric pulses, offering potential reprieve from chronic nausea and vomiting symptoms related to gastroparesis. This therapy is specifically meant for individuals aged 18 to 70 years who are experiencing chronic, unmanageable (drug-refractory) nausea and vomiting associated with gastroparesis of diabetic or idiopathic origin.

Who Are the Leading Market Players Fueling Growth in the Gastroparesis Market Trend?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

How is the Global Gastroparesis Market Segemented?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Which Geographics are Influencing the Growth of the Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Gastroparesis Maret 2025, By The Business Research Company:

Specialty Trade Contractors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/specialty-trade-contractors-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: